TVRD — Tvardi Therapeutics, Inc. · rev $2.6M

Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.

Latest reported TVRD revenue for 2025-03-31 was $2.6M. Net income was -$4.9M. TVRD currently screens at market cap $0.

Use this TVRD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TVRD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TVRD SEC filings page. Lician reads the product cache first so this HTML stays unique to Tvardi Therapeutics, Inc. even when a live quote feed is slow.

Tvardi Therapeutics, Inc. latest statements (FY2025)

Latest cached year on this hub. Full TVRD income, balance, and cash tables.

  • Revenue$0
  • Net Income-$18.2M
  • Total Assets$32.1M
  • Total Debt$0
  • Free Cash Flow$0

TVRD recent filings